{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:45:34Z","timestamp":1761745534662},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.2169\/internalmedicine.8319-21","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T22:09:00Z","timestamp":1631311740000},"page":"1049-1054","source":"Crossref","is-referenced-by-count":3,"title":["Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript"],"prefix":"10.2169","volume":"61","author":[{"given":"Naoki","family":"Miyashita","sequence":"first","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Suto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanase","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ohigashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yasumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Hokkaido University, Japan"},{"name":"Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Faderl S, Talpaz M, Estrov Z, O&apos;Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Engl J Med 341: 164-172, 1999.","DOI":"10.1056\/NEJM199907153410306"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Verma D, Kantarjian HM, Jones D, et al. Chronic myeloid leukemia (CML) with P190<sup>BCR-ABL<\/sup>: analysis of characteristics, outcomes, and prognostic significance. Blood 114: 2232-2235, 2009.","DOI":"10.1182\/blood-2009-02-204693"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122: 872-884, 2013.","DOI":"10.1182\/blood-2013-05-501569"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Weerkamp F, Dekking E, Ng YY, et al. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients. Leukemia 23: 1106-1117, 2009.","DOI":"10.1038\/leu.2009.93"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Manzella L, Tirr\u00f2 E, Vitale SR, et al. Optimal response in a patient with CML expressing <i>BCR-ABL1<\/i> E6A2 fusion transcript with nilotinib therapy: a case report. In Vivo 34: 1481-1486, 2020.","DOI":"10.21873\/invivo.11933"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang Y, Cheng Z, Yan WZ, Liu SF, Hu CH, Zhang GS. Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 <i>BCR-ABL1<\/i> transcript with a somatic mutation in <i>TP53BP2<\/i> and <i>cadherin-10<\/i> genes. Leuk Lymphoma 59: 233-236, 2018.","DOI":"10.1080\/10428194.2017.1323269"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Miao Y, Huang Y, Feng C, Jiang L, Xu H, Chen Z. A rare e9a1 BCR-ABL1 fusion transcript in chronic myeloid leukemia. Int J Lab Hematol 39: e14-e16, 2017.","DOI":"10.1111\/ijlh.12573"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stella S, Massimino M, Tirr\u00f2 E, et al. Detection and clinical implications of a novel <i>BCR-ABL1<\/i> E12A2 insertion\/deletion in a CML patient expressing the E13A2 isoform. Anticancer Res 39: 6965-6971, 2019.","DOI":"10.21873\/anticanres.13918"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Massimino M, Stella S, Tirr\u00f2 E, et al. Efficacy of dasatinib in a very elderly CML patient expressing a rare E13a3 <i>Bcr-Abl1<\/i> fusion transcript: a case report. Anticancer Res 39: 3949-3954, 2019.","DOI":"10.21873\/anticanres.13548"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhao H, Chen Y, Shen C, et al. Breakpoint mapping of a t (9;22;12) chronic myeloid leukaemia patient with e14a3 <i>BCR-ABL1<\/i> transcript using Nanopore sequencing. J Gene Med 23: e3276, 2021.","DOI":"10.1002\/jgm.3276"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Xue M, Wang Q, Huo L, et al. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts. Leuk Lymphoma 60: 3051-3057, 2019.","DOI":"10.1080\/10428194.2019.1607329"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. L\u00f3pez-Andrade B, Sartori F, Guti\u00e9rrez A, et al. Acute lymphoblastic leukemia with e1a3 BCR\/ABL fusion protein. A report of two cases. Exp Hematol Oncol 5: 21, 2015.","DOI":"10.1186\/s40164-016-0049-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sonu RJ, Jonas BA, Dwyre DM, Gregg JP, Rashidi HH. Optimal molecular methods in detecting p190<sup>BCR-ABL<\/sup> fusion variants in hematologic malignancies: a case report and review of the literature. Case Rep Hematol 2015: 1-6, 2015.","DOI":"10.1155\/2015\/458052"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH. Two cases of acute lymphoblastic leukemia with an e1a3 <i>BCR-ABL1<\/i> fusion transcript. Ann Lab Med 35: 159-161, 2015.","DOI":"10.3343\/alm.2015.35.1.159"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion. Acta Haematol 126: 214-215, 2011.","DOI":"10.1159\/000330956"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujisawa S, Nakamura S, Naito K, Kobayashi M, Ohnishi K. A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature. Int J Hematol 87: 184-188, 2008.","DOI":"10.1007\/s12185-008-0031-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Burmeister T, Schwartz S, Taubald A, et al. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica 92: 1699-1702, 2007.","DOI":"10.3324\/haematol.11737"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wilson GA, Vandenberghe EA, Pollitt RC, et al. Are aberrant BCR-ABL transcripts more common than previously thought? Br J Haematol 111: 1109-1111, 2000.","DOI":"10.1046\/j.1365-2141.2000.02471.x"},{"key":"19","first-page":"1696","volume":"8","author":"S Iwata","year":"1994","unstructured":"19. Iwata S, Mizutani S, Nakazawa S, Yata J. Heterogeneity of the breakpoint in the ABL gene in cases with BCR\/ABL transcript lacking ABL exon a2. Leukemia 8: 1696-1702, 1994.","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"20","first-page":"397","volume":"4","author":"D Soekarman","year":"1990","unstructured":"20. Soekarman D, van Denderen J, Hoefsloot L, et al. A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 4: 397-403, 1990.","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"21","unstructured":"21. Chen Y, Wang HW, Chen XH, et al. Adult acute lymphoblastic leukemia with atypical BCR-ABL transcript e1a3: a case report and literature review. Zhonghua Xue Ye Xue Za Zhi (Chin J Hematol) 34: 965-966, 2013."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sheets JW, Eulitt P, He R, et al. Philadelphia chromosome-positive acute myeloid leukemia with e1a3 <i>BCR-ABL1<\/i> Fusion Transcript. Hemasphere 4: e484, 2020.","DOI":"10.1097\/HS9.0000000000000484"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Qin YZ, Jiang Q, Jiang H, et al. Prevalence and outcomes of uncommon <i>BCR-ABL1<\/i> fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. Br J Haematol 182: 693-700, 2018.","DOI":"10.1111\/bjh.15453"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Farhat-Maghribi S, Habbal W, Monem F. Frequency of <i>BCR-ABL<\/i> transcript types in syrian CML patients. J Oncol 2016.","DOI":"10.1155\/2016\/8420853"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tabassum N, Saboor M, Ghani R, Moinuddin M. Heterogeneity of Breakpoint Cluster Region-Abelson (BCR-ABL) rearrangement in patients with chronic myeloid leukemia in Pakistan. Pak J Med Sci 30: 850-853, 2015.","DOI":"10.12669\/pjms.304.4692"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Al-Ali HK, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger M. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood 100: 1092-1093, 2002.","DOI":"10.1182\/blood-2002-03-0930"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Roman J, Jimenez A, Barrios M, Castillejo JA, Maldonado J, Torres A. E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia. Br J Haematol 114: 635-637, 2001.","DOI":"10.1046\/j.1365-2141.2001.02971.x"},{"key":"28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.leu.2401509","volume":"13","author":"G Martinelli","year":"1999","unstructured":"28. Martinelli G, Amabile M, Terragna C, et al. Concamitant expression of the rare E1\/A3 and B2\/A3 types of BCR\/ABL transcript in a chronic myeloid leukemia (CML) patient. Leukemia 13: 1463-1464, 1999.","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Martinez-Serra J, del Campo R, Gutierrez A, et al. Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis. Biomark Res 2: 1-4, 2014.","DOI":"10.1186\/2050-7771-2-14"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hu LH, Pu LF, Yang DD, et al. How to detect the rare BCR-ABL (e14a3) transcript: a case report and literature review. Oncol Lett 14: 5619-5623, 2017.","DOI":"10.3892\/ol.2017.6847"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Skorski T, Nieborowska-Skorska M, Wlodarski P, et al. The SH3 domain contributes to BCR\/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood 91: 406-418, 1998.","DOI":"10.1182\/blood.V91.2.406.406_406_418"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8319-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:10:48Z","timestamp":1715231448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8319-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8319-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"8319-21"}}